Access cutting-edge kidney cancers treatment through this phase 2 clinical trial at a research site in Detroit. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Detroit location
Preparing your pre-screening questions…
Access kidney cancers specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related kidney cancers treatment provided free
Check if you qualify for this kidney cancers clinical trial in Detroit, MI
No-Cost Study Care
Local to Detroit
Convenient for MI residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The goal of this prospective, single-arm feasibility study is to evaluate the safety and feasibility of using Gleolan® (5-aminolevulinic acid), an FDA-approved drug currently used during brain tumor surgery, in adults with suspected kidney cancer undergoing partial nephrectomy. Gleolan has shown promise in improving the visualization of cancerous tissue, and this study aims to assess its potential use in urologic oncology. The main questions it aims to answer are: * Is Gleolan safe and well tolerated in patients with suspected kidney cancer undergoing partial nephrectomy? * Is the use of Gleolan feasible for fluorescence-guided identification of kidney cancer lesions during surgery? Participants will: * Receive Gleolan before surgery according to the study protocol. * Undergo partial nephrectomy, during which fluorescence imaging will be used to evaluate the visualization of kidney tumor tissue. * Be monitored for safety outcomes and any adverse events before, during, and after surgery.
Sponsor: Henry Ford Health System
Yes, this clinical trial (NCT07828704) has an active research site in Detroit, MI that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for kidney cancers treatment options in Detroit, MI, this clinical trial (NCT07828704) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Detroit research site is actively enrolling participants for this phase 2 clinical trial. You'll receive care from experienced kidney cancers specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all kidney cancers clinical trials near you to find additional studies recruiting in your area.
See all kidney cancer clinical trials recruiting in Detroit — not just this study.
Browse Kidney Cancer Trials in Detroit →